Ryu S E, Choi H J, Kwon K S, Lee K N, Yu M H
Protein Engineering Research Division, Korea Research Institute of Bioscience and Biotechnology, KIST, Yusong, Taejon, South Korea.
Structure. 1996 Oct 15;4(10):1181-92. doi: 10.1016/s0969-2126(96)00126-8.
The protein alpha1-antitrypsin is a prototype member of the serpin (serine protease inhibitor) family and is known to inhibit the activity of neutrophil elastase in the lower respiratory tract. Members of this family undergo a large structural rearrangement upon binding to a target protease, involving cleavage of the reactive-site loop. This loop is then inserted into the main body of the enzyme following the opening of a central beta sheet, leading to stabilization of the structure. Random mutageneses of alpha1-antitrypsin identified various mutations that stabilize the native structure and retard the insertion of the reactive-site loop. Structural studies of these mutations may reveal the mechanism of the conformational change.
We have determined the three-dimensional structure of an uncleaved alpha1-antitrypsin with seven such stabilizing mutations (hepta alpha1-antitrypsin) at 2.7 A resolution. From the comparison of the structure with other serpin structures, we found that hepta alpha1-antitrypsin is stabilized due to the release of various strains that exist in native wild type alpha1-antitrypsin, including unfavorable hydrophobic interactions in the central hydrophobic core. The reactive-site loop of hepta alpha1-antitrypsin is an extended strand, different from that of the previously determined structure of another uncleaved alpha1-antitrypsin, and indicates the inherent flexibility of the loop.
The present structural study suggests that the uncleaved alpha1-antitrypsin has many folding defects which can be improved by mutations. These folding defects seem to be utilized in a coordinated fashion in the regulation of the conformational switch of alpha1-antitrypsin. Some of the defects, represented by the Phe51 region and possibly the Met374 and the Thr59 regions, are part of the sheet-opening mechanism.
蛋白质α1-抗胰蛋白酶是丝氨酸蛋白酶抑制剂(serpin)家族的原型成员,已知其可抑制下呼吸道中中性粒细胞弹性蛋白酶的活性。该家族成员在与靶蛋白酶结合后会发生大规模的结构重排,包括反应性位点环的切割。然后,该环在中央β折叠片打开后插入酶的主体中,从而导致结构稳定。对α1-抗胰蛋白酶的随机诱变鉴定出了各种稳定天然结构并延缓反应性位点环插入的突变。对这些突变的结构研究可能揭示构象变化的机制。
我们已确定了一种未切割的α1-抗胰蛋白酶的三维结构,该结构具有七个这样的稳定突变(七聚体α1-抗胰蛋白酶),分辨率为2.7埃。通过将该结构与其他丝氨酸蛋白酶抑制剂结构进行比较,我们发现七聚体α1-抗胰蛋白酶由于天然野生型α1-抗胰蛋白酶中存在的各种张力的释放而得以稳定,包括中央疏水核心中不利的疏水相互作用。七聚体α1-抗胰蛋白酶的反应性位点环是一条延伸链,与先前确定的另一种未切割的α1-抗胰蛋白酶的结构不同,表明该环具有固有的灵活性。
目前的结构研究表明,未切割的α1-抗胰蛋白酶存在许多折叠缺陷,这些缺陷可通过突变得到改善。这些折叠缺陷似乎以协调的方式用于α1-抗胰蛋白酶构象转换的调节。一些缺陷,以苯丙氨酸51区域为代表,可能还有甲硫氨酸374和苏氨酸59区域,是β折叠片打开机制的一部分。